Clinical Trial Update: Antihypertensive Pharmacological Therapy With Mineralocorticoid Receptor Antagonists in Obese Hypertensive Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating mineralocorticoid receptor antagonists for hypertension in obese patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Obesity

Snippet

Sponsor: Hippocration General Hospital | Conditions: Hypertension, Obesity | Phase 4 | Status: COMPLETED